(Q35827155)
Statements
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693 (English)
J P van der Post
S J de Visser
M L de Kam
M Woelfler
D C Hilt
E S Burak
E Bortey
B S Slusher
T Limsakun
A F Cohen
J M A van Gerven
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference